Three Share Nobel Prize for Hepatitis C Analysis


Oct. 5, 2020 — Two U.S. researchers and a British scientist have been awarded the 2020 Nobel Prize in physiology or drugs for main contributions to the combat in opposition to blood-borne hepatitis.

Hepatitis C, which causes cirrhosis and liver cancer, causes 400,000 deaths worldwide annually, the Washington Publish reported.

The three recipients are: Harvey Alter, a medical scientist at a U.S. Nationwide Institutes of Well being blood financial institution; Charles Rice, of the Washington College in St. Louis; and British-born virologist Michael Houghton.

The researchers’ work was described by the Nobel Committee as “a landmark achievement in our battle in opposition to viral infections,” the Publish reported.

WebMD Information from HealthDay

Copyright © 2013-2020 HealthDay. All rights reserved.